Roberta de Freitas Lopes

Prof. Roberta de Freitas Lopes


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ASAna Paula Azevedo Barros da Silva
Ana Paula Azevedo Barros da Silva
RARenata Morais Ferreira Amorim
Renata Morais Ferreira Amorim
RLRoberta de Freitas Lopes
Roberta de Freitas Lopes
MMMário Rogério Lima Mota
Mário Rogério Lima Mota
Felipe Moura Araujo SilvaFelipe Moura Araujo Silva
Felipe Moura Araujo Silva
RCRenildo Moura da Cunha
Renildo Moura da Cunha

20 November 2025 in Plants
Verified
Journal Article
Open access
PDF file
JCJoy Braga Cavalcante
Joy Braga Cavalcante
ASAdriely de Brito Silva
Adriely de Brito Silva
RLRoberta de Freitas Lopes
Roberta de Freitas Lopes
LRLucimar PINHEIRO Rosseto
Lucimar PINHEIRO Rosseto
FMFabiana Aparecida Marques
Fabiana Aparecida Marques
JFJames Oluwagbamigbe Fajemiroye
James Oluwagbamigbe Fajemiroye
Hymenaea spp. (Fabaceae) are widely used in folk medicine to treat fatigue, inflammation, respiratory, and gastrointestinal disorders. However, comprehensive evidence-based evaluations of their pharmacological potential remain limited. This systematic review brought together the existing pharmacological and phytochemical evidence on the significant therapeutic potential of Hymenaea spp. A total of 17 studies were included; phytochemical analyses identified flavonoids, triterpenes, procyanidins, xyloglucans, and caryophyllene oxide among the major bioactive constituents. The reported biological activities were primarily anti-inflammatory, antioxidant, immunomodulatory, antimicrobial, and antiproliferative. Mechanistic findings consistently substantiated anti-inflammatory evidence through COX/LOX inhibition, cytokines, and redox-related modulations. Despite these promising results, the molecular mechanisms and translational evidence remain poorly defined. In conclusion, Hymenaea spp. exhibit significant pharmacological potential. Future studies integrating metabolomics and preclinical and clinical validation are essential to translating traditional knowledge of this species into evidence-based therapeutics.

7 August 2024 in REVISTA DELOS
Verified
Journal Article
Open access
PDF file
ASAna Paula Azevedo Barros da Silva
Ana Paula Azevedo Barros da Silva
APAnny Beatriz Silveira Peixoto
Anny Beatriz Silveira Peixoto
BHBianca Feitosa Holanda
Bianca Feitosa Holanda
RLRoberta de Freitas Lopes
Roberta de Freitas Lopes
AAAna Maria S. Assreuy
Ana Maria S. Assreuy
RCRenildo Moura da Cunha
Renildo Moura da Cunha
Pharmacotherapy for the treatment of inflammation based on non-steroidal anti-inflammatory drugs (NSAIDs) and opioids can cause gastrointestinal discomfort, ulcers, renal, cardiac and metabolic dysfunctions. Studies on natural products containing constituents with anti-inflammatory and analgesic activity remain important and quite justified. Plants belonging to the Rubiaceae family are examples of source of bioactives. The hydroalcoholic extract of Calycophyllum spruceanum (Benth.) Hook. F. ex K. Schum (Mulateiro) leaves (HECsL), native to the Amazon biomes, when subjective to liquid chromatography in UHPLC-MS, revealed the presence of four phenolic constituents: caffeoylquinic derivatives, small organic acids and flavonoids, constituents that have antioxidant and anti-inflammatory activity. HECsL did not show acute toxicity, nor did it change the motor coordination or body mass of the experimental animals. HECsL at a dose of 60 mg/kg reduced the number of writhings induced by 0.8% acetic acid (63%), increased the time spent on the hot plate (30%), and increased the tail withdrawal latency at a dose of 120 mg/kg (49%). The stimulation of hypernociception by carrageenan in the animals abdomen was reversed by HECsL (59%) by decreasing the number of total leukocytes (67%). HECsL has anti-inflammatory and antinociceptive prophylactic effects on the peripheral and central nervous system of Swiss mice, being devoid of acute toxicity.

3 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
JCJoy Braga Cavalcante
Joy Braga Cavalcante
ASAdriely de Brito Silva
Adriely de Brito Silva
RLRoberta de Freitas Lopes
Roberta de Freitas Lopes
LRLucimar PINHEIRO Rosseto
Lucimar PINHEIRO Rosseto
FMFabiana Aparecida Marques
Fabiana Aparecida Marques
JFJames Oluwagbamigbe Fajemiroye
James Oluwagbamigbe Fajemiroye
Hymenaea spp. (Fabaceae), widely used in folk medicine, has been traditionally employed for treating fatigue, inflammatory, respiratory, and gastrointestinal disorders. Despite this, comprehensive evidence-based evaluations of its pharmacological potential remain scarce. A systematic review was conducted across PubMed, Scopus, Web of Science, and SciELO through June 2025, following PRISMA guidelines. Eligible studies included in vitro and in vivo investigations reporting phytochemical or pharmacological data. Two independent reviewers extracted the data, with a third resolving discrepancies. Risk of bias was assessed using the Joanna Briggs Institute checklist. From 186 screened records, 17 studies met the inclusion criteria, underscoring the paucity of rigorous research. Of these, 88.2% (15 studies) were in vitro and 11.8% (2 studies) were in vivo. Phytochemical analyses identified flavonoids, triterpenes, procyanidins, xyloglucans, and caryophyllene oxide. Reported pharmacological activities included anti-inflammatory, antioxidant, immunomodulatory, antimicrobial, and antiproliferative effects. Notably, in vitro studies demonstrated biofilm inhibition of Staphylococcus aureus by xyloglucans. However, mechanistic pathways remain poorly defined. Hymenaea spp. exhibits promising pharmacological potential, but current evidence is limited by the scarcity of mechanistic studies and the absence of standardized clinical trials. Future work integrating metabolomics and advanced pharmacological models is needed to bridge traditional knowledge with modern evidence and to support therapeutic development.

5 May 2026 in Journal of Ethnopharmacology
Verified
Journal Article
Open access
AAAna Maria S. Assreuy
Ana Maria S. Assreuy
RLRoberta de Freitas Lopes
Roberta de Freitas Lopes
FNFrancisco Glerison da Silva Nascimento
Francisco Glerison da Silva Nascimento
DADiego Freitas de Araujo
Diego Freitas de Araujo
MMMatheus Firmino de Morais
Matheus Firmino de Morais
RCRenildo Moura da Cunha
Renildo Moura da Cunha
Dacryodes kukachkana or "breu" is found in the Brazilian Amazon rainforest, being this genus widely used in folk medicine for inflammatory conditions. Experimental studies demonstrated that the hydroethanolic extract of D. kukachkana barks (HEDk), containing phenolic compounds, inhibits inflammatory nociception and healing. To investigate in silico and in vivo the anti-inflammatory mechanisms of the aqueous fraction from D. kukachkana barks (AFDk), along with its phytochemical characterization by UV-vis, FTIR and HPLC-DAD. Mice received per oral (p.o.) HEDk (50-1000 mg/kg) or AFDk (100-500 mg/kg) before paw edema and peritonitis induction with carrageenan, TNF-α, PGE2 or L-arginine to evaluate: edema; hypernociception; leucocyte influx; myeloperoxidase activity (MPO) and nitrite. To search for the pharmacological targets of AFDk, it was performed in silico the possible interaction with its constituents, and in vivo the pharmacological modulation via blockade of NO synthase and guanylate cyclase pathway. UV-Vis and FTIR analyses revealed the phenolic profile of the extract. HPLC-DAD analysis of AFDk revealed the predominant presence of ellagic acid, quercetin, and rutin. At 500 mg/kg HEDk (3-5 h) and AFDk (2-5 h) inhibited edema (53, 54%), hypernociception (62, 60%) and neutrophil migration (70, 74%) induced by carrageenan. AFDk also inhibited MPO (28%) and nitrite (74%) in peritoneal fluid, and the edema induced by PGE2 (78%), TNF-α (72%) and L-arginine (66%). The antiedematogenic effect of AFDk was impaired by ODQ, but not by L-NAME, in line with the in sílico analysis (PTGS2, NOS, ALOX5). the anti-inflammatory effect of AFDK was mediated by PGE2, TNF- α, and L-arginine/NO/cGMP pathway.